Farrell Michael J.
- SEC CIK
- 0001485164
In the past year, 12 open-market sale filings worth $15.7M and no purchases.
Current role at each company
- RMD Resmed IncChairman and CEOas of Sep 10, 2026
- ZBH Zimmer Biomet Holdings, Inc.Directoras of Jul 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $15.7M
- 12 filings
- Net
- −$15.7M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Farrell Michael J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RMD Resmed Inc
Chairman and CEO53 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 (view filing)6:40 AM ET | Sep 8 | 2 days | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $222.44 | −$1.11M | −1.1%466.3K after | 10b5-1 |
| Aug 11, 2026 (view filing)6:30 AM ET | Aug 7 | 4 days | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $205.69 | −$1.03M | −1.1%466.3K after | 10b5-1 |
| Jul 9, 2026 (view filing)7:40 AM ET | Jul 7 | 2 days | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $218.55 | −$1.09M | −1.1%466.2K after | 10b5-1 |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $193.96 | −$968.1K | −1.1%466.3K after | 10b5-1 |
| May 11, 2026 (view filing) | May 7 | 4 days | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $207.82 | −$1.04M | −1.1%466.2K after | 10b5-1 |
| Apr 9, 2026 (view filing) | Apr 7 | 2 days | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $225.50 | −$1.13M | −1.1%466.2K after | 10b5-1 |
| Mar 11, 2026 (view filing) | Mar 9 | 2 days | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $251.03 | −$1.25M | −1.1%466.2K after | 10b5-1 |
| Feb 10, 2026 (view filing) | Feb 9 | 1 day | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $273.78 | −$1.37M | −1.1%466.2K after | 10b5-1 |
| Jan 8, 2026 (view filing) | Jan 7 | 1 day | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $248.46 | −$1.24M | −1.1%466.2K after | 10b5-1 |
| Dec 9, 2025 (view filing) | Dec 8 | 1 day | Farrell Michael J.Chairman and CEO | SSaleResMed Common Stock | −4.99K | $251.41 | −$1.25M | −1.1%466.2K after | 10b5-1 |